Found: 6
Select item for more details and to access through your institution.
The association of flushing bother, impact, treatment satisfaction and discontinuation of niacin therapy.
- Published in:
- International Journal of Clinical Practice, 2013, v. 67, n. 12, p. 1238, doi. 10.1111/ijcp.12213
- By:
- Publication type:
- Article
Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucose.
- Published in:
- International Journal of Clinical Practice, 2013, v. 67, n. 4, p. 297, doi. 10.1111/ijcp.12089
- By:
- Publication type:
- Article
Extended-release niacin/laropiprant lipid-altering consistency across patient subgroups.
- Published in:
- International Journal of Clinical Practice, 2011, v. 65, n. 4, p. 436, doi. 10.1111/j.1742-1241.2010.02620.x
- By:
- Publication type:
- Article
Efficacy and safety of extended-release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia.
- Published in:
- International Journal of Clinical Practice, 2010, v. 64, n. 6, p. 727, doi. 10.1111/j.1742-1241.2010.02370.x
- By:
- Publication type:
- Article
Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Safety and efficacy of ezetimibe monotherapy in 1624 primary hypercholesterolaemic patients for up to 2 years.
- Published in:
- International Journal of Clinical Practice, 2008, v. 62, n. 9, p. 1332, doi. 10.1111/j.1742-1241.2008.01798.x
- By:
- Publication type:
- Article